Rademikibart for Asthma With Type 2 Biomarkers: Exploratory Subgroup Analyses From a Phase 2b Randomized Clinical Trial

Michael E. Wechsler, Praveen Akuthota, Barry Quart, Raúl Collazo
Allergy: European Journal of Allergy and Clinical Immunology · Wiley · 2026-09-10 · DOI: 10.1111/all.70506

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles